CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CASI Pharmaceuticals's price to sales ratio was 0.1× on Oct 19, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.1× to 7.8×, with a median of 1.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.1× | −0.4 |
| 2025 | Dec 31, 2025 | 0.5× | −0.7 |
| 2024 | Dec 31, 2024 | 1.1× | −1.1 |
| 2023 | Dec 29, 2023 | 2.2× | +1.4 |
| 2022 | Dec 30, 2022 | 0.8× | −5.0 |
| 2021 | Dec 31, 2021 | 5.8× | – |
See a number that looks wrong?